Skip to content

KWF

INTER-LOCAL – International Call for Clinical Research on Rare and Hard-to-Treat Cancers

Sketch deadline was 22 January 2026 at 12:00 — check KWF for current status

Last verified:

Is this grant right for you? Check your personalised match score. 30s, no email. See my matches →

INTER-LOCAL is a joint European call from five leading cancer charities, including KWF, funding clinical research on local treatment strategies for rare and hard-to-treat cancers. The call requires international consortium participation and operates in two stages: sketch and full proposal. This one-off call addresses urgent clinical gaps where patients have limited treatment options.

Details

Funder KWF
Consortium Required — international collaboration across participating countries
Application 2-stage: sketch/pre-proposal → full proposal
Frequency One-off
Eligible countries NL

Eligibility & scope

Joint call by five leading European cancer charities to accelerate clinical research on local treatment strategies for rare and hard-to-treat cancers. Aims to address urgent need for more effective treatments for patients with limited options. Full call text via KWF (Dutch Cancer Society).

Who Should Apply

  • Clinical research teams with expertise in rare or hard-to-treat cancers
  • Researchers based at Dutch institutions (eligible countries: NL)
  • Consortia spanning at least two participating European countries
  • Projects focusing on local treatment innovation (surgery, radiation, or regional therapies)

Key Dates

  • Sketch deadline: 22 January 2026 at 12:00 (verify current status on KWF website)
  • Two-stage evaluation: sketch/pre-proposal → full proposal
  • One-off call

Tips for Applicants

  • Consortium building is mandatory and competitive; identify co-applicants from participating European countries early.
  • The sketch stage filters on clinical urgency and unmet need, lead with patient impact, not technical detail.
  • KWF coordinates this joint call; check their website for co-funder eligibility rules, which may vary by country partner.

Frequently Asked Questions

Is INTER-LOCAL a one-time call or does it recur?

INTER-LOCAL is a one-off joint call from five European cancer charities; there is no stated plan for future rounds.

Do I need an international consortium to apply to INTER-LOCAL?

Yes, the call requires international collaboration across participating European countries; applications from single-country teams are not eligible.

What types of cancers does INTER-LOCAL fund?

The call targets rare and hard-to-treat cancers with a focus on local treatment strategies (surgical, radiation-based, or regional approaches) where patients currently have limited options.

What is the sketch deadline for INTER-LOCAL?

The sketch deadline was 22 January 2026 at 12:00; check the KWF website to confirm the current status of this call.

cancer-biologyclinical-trialskwfrare-cancerconsortium-requiredhard-to-treat-cancerlocal-treatmentinternational

Related on Grantsby

Summary generated by AI based on published grant information. Always verify details on the funder's website.

More from KWF

Browse all open grants →

Browse Related

Could INTER-LOCAL – International Call for Clinical Research on Rare and Hard-to-Treat Cancers be right for you?

See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.

See my matches free →